Patents by Inventor Maha Hussain

Maha Hussain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating cancer
    Patent number: 11969419
    Abstract: This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
    Type: Grant
    Filed: February 21, 2023
    Date of Patent: April 30, 2024
    Assignee: Exelixis, Inc.
    Inventors: David Smith, Maha Hussain
  • Method of Treating Cancer
    Publication number: 20230301980
    Abstract: This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
    Type: Application
    Filed: February 21, 2023
    Publication date: September 28, 2023
    Inventors: David Smith, Maha Hussain
  • Method of treating cancer
    Patent number: 11612597
    Abstract: This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: March 28, 2023
    Assignee: Exelixis, Inc.
    Inventors: David Smith, Maha Hussain
  • Method of Treating Cancer
    Publication number: 20200330450
    Abstract: This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
    Type: Application
    Filed: June 18, 2020
    Publication date: October 22, 2020
    Inventors: David Smith, Maha Hussain
  • Method of Treating Cancer
    Publication number: 20160220554
    Abstract: This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
    Type: Application
    Filed: September 2, 2015
    Publication date: August 4, 2016
    Inventors: David C. Smith, Maha Hussain
  • Method of Treating Cancer
    Publication number: 20140066444
    Abstract: This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
    Type: Application
    Filed: September 26, 2011
    Publication date: March 6, 2014
    Applicant: Exelixis, Inc.
    Inventors: David C. Smith, Maha Hussain
  • Method of Treating Cancer
    Publication number: 20140057908
    Abstract: This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
    Type: Application
    Filed: September 26, 2011
    Publication date: February 27, 2014
    Applicant: Exelixis, Inc.
    Inventors: David C. Smith, Maha Hussain
  • Method of Treating Cancer
    Publication number: 20140057943
    Abstract: This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
    Type: Application
    Filed: September 26, 2011
    Publication date: February 27, 2014
    Applicant: Exelixix, Inc.
    Inventors: David C. Smith, Maha Hussain